Crescent Biopharma, Inc.CBIONASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank79
3Y CAGR+32.6%
5Y CAGR+28.2%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+32.6%/yr
vs -31.4%/yr prior
5Y CAGR
+28.2%/yr
Recent acceleration
Acceleration
+64.0pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
3.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.67M | +161.7% |
| 2024 | $-2.70M | -213.8% |
| 2023 | $2.38M | +232.4% |
| 2022 | $714963.00 | +3516.8% |
| 2021 | $19768.00 | -95.9% |
| 2020 | $482487.00 | -86.2% |
| 2019 | $3.50M | +8.2% |
| 2018 | $3.23M | +396.2% |
| 2017 | $651212.00 | +528.3% |
| 2016 | $103647.00 | - |